AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20862947 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture RCTs in the United States
Number of subjects: 0
Study 20862947 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture RCTs
Number of subjects: 0
Study 19081527 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab induction (5 mg/kg/dose) at weeks 0, 2, and 6; maintenance therapy every 8 or 12 weeks
Number of subjects: 112
Study 16093871 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg on demand for 6 months
Number of subjects: 536
Study 16093871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 536
Study 11870412 — intervention group
Group type: EXPERIMENTAL
Intervention: Orocal D3 (500 mg Ca and 400 IU vitamin D) taken in two doses 6 hours apart
Number of subjects: 12
Study 11870412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cacit D3 (1000 mg Ca and 880 IU vitamin D) taken as a single morning dose
Number of subjects: 12
Study 11870412 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug intake)
Number of subjects: 12
Study 10408075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiotocography
Number of subjects: 25
Study 10408075 — intervention group
Group type: COMPARATOR
Intervention: Control group (paired cases without cord complications)
Number of subjects: 25
Study 10408075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraobserver variability
Number of subjects: 25
Study 7584524 — intervention group
Group type: COMPARATOR
Intervention: Clonidine (0.3 mg)
Number of subjects: 12
Study 7584524 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine (0.3 mg)
Number of subjects: 12
Study 7584524 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg i.v.)
Number of subjects: 12
Study 2248350 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal cues
Number of subjects: 28
Study 2248350 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues
Number of subjects: 28
Study 2248350 — intervention group
Group type: COMPARATOR
Intervention: Uncued test
Number of subjects: 28
Study 2248350 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued test
Number of subjects: 28
Study 7011226 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (1,300 mg daily) and dipyridamole (100 mg daily)
Number of subjects: 113
Study 7011226 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 113
Study 7011226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IMA-LAD grafts)
Number of subjects: 113
Study 30736832 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic-based exercise intervention (thrice-weekly, moderate-intensity aerobic exercise supplemented with isometric resistance exercise)
Number of subjects: 160
Study 30736832 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 160
Study 30736832 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic-based exercise intervention
Number of subjects: 160
Study 30953791 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 50% maximum inspiratory pressure (MIP) for 4 weeks, 30 breaths twice daily
Number of subjects: 42
Study 30953791 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for smokers
Number of subjects: 42
Study 30953791 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (15% MIP for 4 weeks, 30 breaths twice daily)
Number of subjects: 42
Study 28350830 — intervention group
Group type: EXPERIMENTAL
Intervention: MVPA intervention (n = 10 SDCs)
Number of subjects: 1830
Study 28350830 — intervention group
Group type: COMPARATOR
Intervention: Healthy eating attention control (n = 10 SDCs)
Number of subjects: 1830
Study 25307931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 1212
Study 25307931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 1212
Study 25307931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (with dosing adjustments)
Number of subjects: 1212
Study 25307931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (overall treatment)
Number of subjects: 1212
Study 25307931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (safety profile)
Number of subjects: 1212
Study 25307931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1212
Study 24046302 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 2495
Study 21898590 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneously every 6 months for 3 years)
Number of subjects: 1468
Study 21898590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1468
Study 18061174 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 18061174 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropins
Number of subjects: 0
Study 16864821 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity-dependent conduction block (ADCB) test after 1 minute of maximal voluntary contraction (magnetic fatigue test)
Number of subjects: 9
Study 16864821 — intervention group
Group type: EXPERIMENTAL
Intervention: IV immunoglobulins (IVIgs)
Number of subjects: 9
Study 16864821 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration from the onset to the positive peak of the CMAP
Number of subjects: 9
Study 12458383 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan + rifaximin (400 mg twice daily for 7 days every month)
Number of subjects: 968
Study 12458383 — intervention group
Group type: COMPARATOR
Intervention: Glucomannan alone (4 g/day)
Number of subjects: 968
Study 11148445 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mesalazine 4 g
Number of subjects: 130
Study 11148445 — intervention group
Group type: COMPARATOR
Intervention: Combined mesalazine 2 g orally plus 2 g rectally as a liquid enema
Number of subjects: 130
Study 9106834 — intervention group
Group type: EXPERIMENTAL
Intervention: Elated mood induction (film fragments expressing happiness and euphoria)
Number of subjects: 60
Study 9106834 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood induction (frightening and distressing film fragments)
Number of subjects: 60
Study 9106834 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction (no film)
Number of subjects: 60
Study 7687443 — intervention group
Group type: EXPERIMENTAL
Intervention: 3H-spiperone binding in patients with PD not treated with L-DOPA
Number of subjects: 123
Study 7687443 — intervention group
Group type: EXPERIMENTAL
Intervention: 3H-spiperone binding in parkinsonian patients with PD treated with L-DOPA
Number of subjects: 123
Study 7687443 — intervention group
Group type: EXPERIMENTAL
Intervention: 3H-spiperone binding in patients with essential tremor
Number of subjects: 123
Study 7687443 — intervention group
Group type: COMPARATOR
Intervention: 3H-spiperone binding in healthy control persons
Number of subjects: 123
Study 3576156 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with 1-2% carbonated lidocaine
Number of subjects: 1000
Study 3576156 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1000
Study 29182402 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual performance
Number of subjects: 5
Study 29182402 — intervention group
Group type: EXPERIMENTAL
Intervention: Team performance
Number of subjects: 5
Study 29182402 — intervention group
Group type: EXPERIMENTAL
Intervention: Team process quality
Number of subjects: 5
Study 29182402 — intervention group
Group type: EXPERIMENTAL
Intervention: Teams with highly engaged recorders
Number of subjects: 5
Study 26643072 — intervention group
Group type: EXPERIMENTAL
Intervention: RESTORE web-based intervention
Number of subjects: 163
Study 26643072 — intervention group
Group type: COMPARATOR
Intervention: Leaflet (control group)
Number of subjects: 163
Study 24461045 — intervention group
Group type: EXPERIMENTAL
Intervention: Established lifestyle intervention
Number of subjects: 43
Study 24461045 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin use during pregnancy
Number of subjects: 43
Study 24461045 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to participation
Number of subjects: 43
Study 22489521 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster splint of U‐shape to the posture with inversion, internal rotation and plantar flexion (Group A)
Number of subjects: 46
Study 22489521 — intervention group
Group type: COMPARATOR
Intervention: Plaster splint of U‐shape to the posture with inversion, internal rotation and dorsiflexion (Group B)
Number of subjects: 46
Study 20956792 — intervention group
Group type: EXPERIMENTAL
Intervention: H-coil rTMS
Number of subjects: 12
Study 20956792 — intervention group
Group type: EXPERIMENTAL
Intervention: C-coil rTMS
Number of subjects: 12
Study 20956792 — intervention group
Group type: COMPARATOR
Intervention: S-coil rTMS
Number of subjects: 12
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term IOP fluctuation (measured as standard deviation of IOP)
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean IOP
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Low mean IOP group
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: High mean IOP group
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower and upper terciles of IOP fluctuation
Number of subjects: 301
Study 18082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean IOP and IOP fluctuation correlation
Number of subjects: 301
Study 17162239 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 15316
Study 14620304 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental acupuncture
Number of subjects: 30
Study 14620304 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterosegmental superficial acupuncture
Number of subjects: 30
Study 14620304 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment only, regional inferior dental block)
Number of subjects: 30
Study 14620304 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental acupuncture vs Heterosegmental superficial acupuncture
Number of subjects: 30
Study 14620304 — intervention group
Group type: COMPARATOR
Intervention: Segmental acupuncture vs Control
Number of subjects: 30
Study 14620304 — intervention group
Group type: COMPARATOR
Intervention: Heterosegmental superficial acupuncture vs Control
Number of subjects: 30
Study 10648334 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 20 mg/kg (AS)
Number of subjects: 65
Study 10648334 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 40 mg/kg (AL)
Number of subjects: 65
Study 10648334 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 20 mg/kg + Diclofenac 100 mg (C)
Number of subjects: 65
Study 8660161 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized grading of fundus photographs
Number of subjects: 0
Study 8660161 — intervention group
Group type: COMPARATOR
Intervention: Clinical evaluation at participating centers
Number of subjects: 0
Study 2916452 — intervention group
Group type: EXPERIMENTAL
Intervention: 800-kcal/d liquid diet with 6% of calories as LCT and 24% as MCT (group 2)
Number of subjects: 0
Study 2916452 — intervention group
Group type: COMPARATOR
Intervention: 800-kcal/d liquid diet with 30% of calories as LCT (group 1)
Number of subjects: 0
Study 2916452 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MCT and LCT)
Number of subjects: 0
Study 12850 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 150 mg/day
Number of subjects: 0
Study 12850 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 300 mg/day
Number of subjects: 0
Study 12850 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa 750 mg/day
Number of subjects: 0
Study 12850 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa 1500 mg/day
Number of subjects: 0
Study 12850 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 150 mg/day and Methyldopa 750 mg/day (combined treatment)
Number of subjects: 0
Study 12850 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa (lower dose)
Number of subjects: 0
Study 12850 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (lower dose)
Number of subjects: 0
Study 31383238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 150
Study 31383238 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy (SRT)
Number of subjects: 150
Study 31383238 — intervention group
Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE)
Number of subjects: 150
Study 28778047 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1g, b.i.d)
Number of subjects: 41
Study 28778047 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone (4mg, b.i.d)
Number of subjects: 41
Study 28778047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 28778047 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin in rats
Number of subjects: 41
Study 26303628 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented PHILOS plates
Number of subjects: 6
Study 26303628 — intervention group
Group type: COMPARATOR
Intervention: Non-augmented PHILOS plates
Number of subjects: 6
Study 23746615 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-based cognitive training (AT) plus social-cognition training (SCT)
Number of subjects: 22
Study 23746615 — intervention group
Group type: COMPARATOR
Intervention: Non-specific computer games (CG)
Number of subjects: 22
Study 22019970 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple needling
Number of subjects: 45
Study 22019970 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified acupuncture (AcP)
Number of subjects: 45
Study 22019970 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (sham AcP)
Number of subjects: 45
Study 19334068 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m², four weekly infusions)
Number of subjects: 26
Study 19334068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 19334068 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 26
Study 22965186 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 17922
Study 15948237 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg/d for 6 months (group 1 and group 2)
Number of subjects: 37
Study 15948237 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg/d for 12 months (group 1 and group 2)
Number of subjects: 37
Study 15948237 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment, group 3 and group 4)
Number of subjects: 37
Study 12725187 — intervention group
Group type: EXPERIMENTAL
Intervention: Blow oxygen method
Number of subjects: 28
Study 12725187 — intervention group
Group type: COMPARATOR
Intervention: Control group (only tube insertion)
Number of subjects: 28
Study 9615374 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke patients
Number of subjects: 221
Study 9615374 — intervention group
Group type: COMPARATOR
Intervention: Age- and sex-matched controls
Number of subjects: 221
Study 8080893 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg orally three times a week, 25 mg twice a week for the first 2 weeks)
Number of subjects: 32
Study 8080893 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 32
Study 8080893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 2676649 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ketorolac
Number of subjects: 115
Study 2676649 — intervention group
Group type: COMPARATOR
Intervention: Doleron (two tablets: 150 mg dextropropoxyphene napsylate, 350 mg aspirin, 150 mg phenazone)
Number of subjects: 115
Study 2676649 — intervention group
Group type: COMPARATOR
Intervention: Doleron (two tablets)
Number of subjects: 115
Study 861482 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated static compression stockings
Number of subjects: 70
Study 861482 — intervention group
Group type: COMPARATOR
Intervention: Control leg (no stockings)
Number of subjects: 70
Study 29650706 — intervention group
Group type: EXPERIMENTAL
Intervention: AD-HFpEF
Number of subjects: 0
Study 29650706 — intervention group
Group type: COMPARATOR
Intervention: S-HFpEF
Number of subjects: 0
Study 26323054 — intervention group
Group type: EXPERIMENTAL
Intervention: manual-guided cognitive behavioral therapy (CBT) for insomnia
Number of subjects: 66
Study 25115308 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific training
Number of subjects: 144
Study 25115308 — intervention group
Group type: COMPARATOR
Intervention: Prescribed physical activity
Number of subjects: 144
Study 23423417 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of procalcitonin to guide antibiotic prescriptions
Number of subjects: 0
Study 19766209 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive pills and metformin
Number of subjects: 164
Study 18537126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster mean imputation
Number of subjects: 0
Study 18537126 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputation (pooled across clusters)
Number of subjects: 0
Study 18537126 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard multiple imputation (not accounting for intracluster correlation)
Number of subjects: 0
Study 18537126 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized multiple imputation (accounting for intracluster correlation)
Number of subjects: 0
Study 18537126 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-cluster multiple imputation
Number of subjects: 0
Study 15959425 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride 1 mg once daily
Number of subjects: 0
Study 15959425 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide 1.25 mg twice daily
Number of subjects: 0
Study 15959425 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 0
Study 15959425 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 0
Study 15959425 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 0
Study 12919990 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with algorithm and instant camera for diagnosis
Number of subjects: 468
Study 12919990 — intervention group
Group type: COMPARATOR
Intervention: Control group (no algorithm or camera)
Number of subjects: 468
Study 12919990 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 468
Study 12919990 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 468
Study 10065089 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI with MFFM (Mitoxantrone, Mitomycin C, 5-FU + FA)
Number of subjects: 222
Study 10065089 — intervention group
Group type: COMPARATOR
Intervention: HAI with 5-FUDR
Number of subjects: 222
Study 10065089 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy with 5-FU + FA
Number of subjects: 222
Study 10065089 — intervention group
Group type: COMPARATOR
Intervention: HAI with 5-FU + FA
Number of subjects: 222
Study 10065089 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary liver resection after HAI with MFFM
Number of subjects: 222
Study 7546063 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial coverage helmet
Number of subjects: 50
Study 7546063 — intervention group
Group type: EXPERIMENTAL
Intervention: Full coverage helmet
Number of subjects: 50
Study 7546063 — intervention group
Group type: COMPARATOR
Intervention: No helmet
Number of subjects: 50
Study 7546063 — intervention group
Group type: EXPERIMENTAL
Intervention: All helmet conditions
Number of subjects: 50
Study 1683183 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam
Number of subjects: 0
Study 1683183 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0
Study 1683183 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 0
Study 1683183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6275468 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant cerebral irradiation (30 grays to the brain overall in 10 fractions over two weeks)
Number of subjects: 33
Study 6275468 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 grays to the brain overall in 10 fractions over two weeks)
Number of subjects: 33
Study 6275468 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant cerebral irradiation
Number of subjects: 33
Study 6275468 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 30117164 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1,200 mg/day)
Number of subjects: 0
Study 27761741 — intervention group
Group type: COMPARATOR
Intervention: bifrontal tDCS
Number of subjects: 40
Study 27761741 — intervention group
Group type: EXPERIMENTAL
Intervention: multisite treatment of bifrontal tDCS before bilateral auditory cortex tRNS
Number of subjects: 40
Study 26116470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (DB) at stepwise doses of 5‐10‐15‐20 μg/kg/min
Number of subjects: 127
Study 26116470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 23357149 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Lp(a) apheresis
Number of subjects: 30
Study 23357149 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 30
Study 21343239 — intervention group
Group type: EXPERIMENTAL
Intervention: RVP-max (maximal right ventricular pacing)
Number of subjects: 22
Study 21343239 — intervention group
Group type: COMPARATOR
Intervention: RVP-min (minimal right ventricular pacing)
Number of subjects: 22
Study 19757014 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood disadvantage, social support, negative affect/perceived stress
Number of subjects: 399
Study 19757014 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect/perceived stress
Number of subjects: 399
Study 19757014 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy, community, and individual-level interventions
Number of subjects: 399